Rhumbline Advisers increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 8.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 94,156 shares of the medical technology company’s stock after purchasing an additional 7,395 shares during the quarter. Rhumbline Advisers owned 0.21% of Teleflex worth $22,783,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Toronto Dominion Bank lifted its position in Teleflex by 244.4% during the third quarter. Toronto Dominion Bank now owns 1,901 shares of the medical technology company’s stock worth $460,000 after purchasing an additional 1,349 shares during the period. Security Asset Management lifted its position in Teleflex by 32.9% during the third quarter. Security Asset Management now owns 6,458 shares of the medical technology company’s stock worth $1,563,000 after purchasing an additional 1,600 shares during the period. BNP Paribas Arbitrage SA lifted its position in Teleflex by 133.0% during the third quarter. BNP Paribas Arbitrage SA now owns 47,109 shares of the medical technology company’s stock worth $11,399,000 after purchasing an additional 26,894 shares during the period. Swiss National Bank lifted its position in Teleflex by 1.2% during the third quarter. Swiss National Bank now owns 165,600 shares of the medical technology company’s stock worth $40,070,000 after purchasing an additional 2,000 shares during the period. Finally, Scout Investments Inc. bought a new stake in Teleflex during the third quarter worth about $14,156,000. 89.11% of the stock is owned by institutional investors and hedge funds.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $241.88, for a total value of $48,376.00. Following the completion of the sale, the director now owns 8,080 shares of the company’s stock, valued at approximately $1,954,390.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In the last three months, insiders sold 600 shares of company stock valued at $138,162. 2.39% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Teleflex Incorporated (TFX) Position Raised by Rhumbline Advisers” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://sportsperspectives.com/2017/11/20/teleflex-incorporated-tfx-position-raised-by-rhumbline-advisers.html.
Several research firms recently weighed in on TFX. Needham & Company LLC upped their price objective on shares of Teleflex from $228.00 to $237.00 and gave the stock a “buy” rating in a research report on Tuesday, September 5th. Piper Jaffray Companies started coverage on shares of Teleflex in a report on Friday, November 10th. They issued an “overweight” rating and a $295.00 target price for the company. Morgan Stanley upgraded shares of Teleflex from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $220.00 to $274.00 in a report on Wednesday, September 6th. KeyCorp reiterated a “hold” rating on shares of Teleflex in a report on Wednesday, September 6th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $253.00 target price (up previously from $230.00) on shares of Teleflex in a research report on Wednesday, August 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have issued a buy rating to the company’s stock. Teleflex presently has an average rating of “Hold” and an average target price of $274.44.
Shares of Teleflex Incorporated (NYSE:TFX) opened at $266.21 on Monday. The company has a market capitalization of $11,992.57, a price-to-earnings ratio of 32.91, a PEG ratio of 2.28 and a beta of 1.05. Teleflex Incorporated has a 52 week low of $142.97 and a 52 week high of $266.45. The company has a debt-to-equity ratio of 0.88, a quick ratio of 3.70 and a current ratio of 4.72.
Teleflex (NYSE:TFX) last released its earnings results on Thursday, November 2nd. The medical technology company reported $2.12 EPS for the quarter, topping the Zacks’ consensus estimate of $2.01 by $0.11. Teleflex had a return on equity of 16.27% and a net margin of 12.41%. The company had revenue of $534.70 million for the quarter, compared to analysts’ expectations of $522.94 million. During the same period in the previous year, the business posted $1.80 EPS. The business’s revenue for the quarter was up 17.3% compared to the same quarter last year. research analysts predict that Teleflex Incorporated will post 8.35 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Investors of record on Wednesday, November 15th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.51%. The ex-dividend date is Tuesday, November 14th. Teleflex’s dividend payout ratio (DPR) is currently 24.82%.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.